Posted On: 08/02/2014 12:35:58 PM
Post# of 74573
$AMGN News
Small health companies see large gains on a big earnings day 5:34 p.m. July 30, 2014 - Russ Britt
Twitter, U.S. Steel soar; Buffalo Wild Wings are burned 4:26 p.m. July 30, 2014 - Sue Chang
Edwards, Hospira rise as health-care companies see strong earnings 1:08 p.m. July 30, 2014 - Russ Britt
Amgen shares hit record on cost-cutting plans 10:50 a.m. July 30, 2014 - Russ Britt
Twitter shines; Fed statement and GDP due today 4:38 a.m. July 30, 2014 - MarketWatch
Amgen plans to cut up to 2,900 jobs 9:04 p.m. July 29, 2014 - MarketWatch.com
Twitter soars 33% in after hours as results surprise on upside 4:56 p.m. July 29, 2014 - Sue Chang
Amgen share climb 3.6% in after-hours trade after raised EPS outlook 4:38 p.m. July 29, 2014 - Tomi Kilgore
Amgen to cut up to 15% of workforce, ups EPS view 4:37 p.m. July 29, 2014 - MarketWatch.com
Amgen Q2 FactSet sales consensus $4.9 bln 4:31 p.m. July 29, 2014 - Jim Jelter
Amgen Q2 sales $5.18 bln vs $4.68 bln a year ago 4:31 p.m. July 29, 2014 - Jim Jelter
Amgen Q2 FactSet EPS consensus $2.07 4:30 p.m. July 29, 2014 - Jim Jelter
Amgen Q2 EPS $2.01 4:29 p.m. July 29, 2014 - Jim Jelter
The Fed meets; Twitter and Amex report results 4:32 a.m. July 29, 2014 - MarketWatch
The market in a minute: What will GDP mean for the market? 12:47 p.m. July 28, 2014 - The Trading Deck
PetSmart gains on Jana stake; Lorillard rallies 1:37 p.m. July 3, 2014 - Sue Chang
Synnex shares decline as outlook edges earnings 5:20 p.m. July 2, 2014 - Wallace Witkowski
Cytokinetics plunges 60% after Lou Gehrig's disease drug fails test 10:26 a.m. April 25, 2014 - Russ Britt
Apple, Facebook stuck in red ahead of earnings 3:03 p.m. April 23, 2014 - Sue Chang
Game day for Facebook and Apple, volume 'signalling the nasty' 6:50 a.m. April 23, 2014 - Barbara Kollmeyer
3 Stocks Reiterated As A Buy: VZ, QCOM, AMGN 12:44 p.m. Aug. 1, 2014 - TheStreet.com
Do Layoffs in Biotech Send the Right Message? 9:45 a.m. Aug. 1, 2014 - 247WallSt.com
Amgen Makes the Cut 12:25 p.m. July 31, 2014 - Barrons.com
Stock Market News for July 31, 2014 - Market News 10:10 a.m. July 31, 2014 - Zacks.com
Biotech Earnings Put These ETFs in Focus - ETF News And Commentary 10:01 a.m. July 31, 2014 - Zacks.com
Nasdaq Threatens to Break Double-Top 9:11 p.m. July 30, 2014 - InvestorPlace.com
Drug Firms Buy $67.5 Million Voucher to Speed FDA Review 7:21 p.m. July 30, 2014 - The Wall Street Journal Interactive Edition
Amgen - Continued Appeal With Shares Trading At Fresh All-Time Highs 5:25 p.m. July 30, 2014 - Seeking Alpha
U.S. Stocks End Mixed 4:31 p.m. July 30, 2014 - The Wall Street Journal Interactive Edition
Stock Market Today: Stocks Mixed as Fed Cuts Bond Buying to $25 Billion 4:31 p.m. July 30, 2014 - TheStreet.com
Stocks Mixed Despite Better-Than-Expected GDP 3:43 p.m. July 30, 2014 - benzinga.com
Stock Market Today: Stocks Slip Ahead of Fed Policy Announcement 1:50 p.m. July 30, 2014 - TheStreet.com
Amgen Price Target Raised by Various Analysts 12:42 p.m. July 30, 2014 - benzinga.com
Amgen Pleases the Street -- but Will Layoffs Keep Critics at Bay? 11:05 a.m. July 30, 2014 - TheStreet.com
Amgen Restructuring Plan, Q2 Earnings Send Stock Up 10:20 a.m. July 30, 2014 - Investors Business Daily
Stock Market News for July 30, 2014 - Market News 10:10 a.m. July 30, 2014 - Zacks.com
Trade-Ideas: Amgen (AMGN) Is Today's New Lifetime High Stock 9:45 a.m. July 30, 2014 - TheStreet.com
Amgen Beats on Q2 Earnings & Revs, Ups View & Plans Job Cuts - Analyst Blog 9:20 a.m. July 30, 2014 - Zacks.com
Will This Price Target Increase Help Amgen (AMGN) Stock Today? 9:02 a.m. July 30, 2014 - TheStreet.com
Amgen Reports Stellar Earnings, Raises Guidance 8:00 a.m. July 30, 2014 - benzinga.com
RBCC 3D Bioprinting Partner Awarded Prestigious Grant 6:54 a.m. July 31, 2014 - BusinessWire - BZX
Resilinc Named 2014 Great Supply Chain Partner by SupplyChainBrain 10:00 a.m. July 30, 2014 - Marketwire
Global Women%s Health Market 2014-2018 6:20 p.m. July 28, 2014 - PR Newswire - PRF
Amgen Announces 2014 Third Quarter Dividend 4:00 p.m. July 25, 2014 - PR Newswire - PRF
Bayer and Onyx Pharmaceuticals Report Phase 3 Trial Results of NEXAVAR® (sorafenib) in Patients with Advanced Breast Cancer 2:30 a.m. July 25, 2014 - PR Newswire - PRF
Amgen Announces Webcast of 2014 Second Quarter Financial Results 4:00 p.m. July 24, 2014 - PR Newswire - PRF
Surveyed U.S. and EU5 Dermatologists Indicate that Short-Term and Long-Term Effects on Psoriatic Plaque Clearance are Two Attributes that Most Strongly Influence Prescribing Decisions in Moderate to Severe Psoriasis 2:00 p.m. July 24, 2014 - PR Newswire - PRF
Amgen's Evolocumab is Set to Become the Clinical Gold-Standard Among Statin Add-On Therapies for Dyslipidemia 10:00 a.m. July 21, 2014 - PR Newswire - PRF
Colorado BioScience Association Recognizes Amgen Foundation’s $25,000 Investment in STEM Education in Colorado’s Classrooms 9:00 a.m. July 21, 2014 - BusinessWire - BZX
Amgen Announces Positive Phase 3 Results for AMG 416 for the Treatment of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease Receiving Hemodialysis 4:01 p.m. July 17, 2014 - PR Newswire - PRF
Global Pharmaceutical Survey 2013-2014 - Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry 4:27 p.m. July 15, 2014 - PR Newswire - PRF
Critical Alerts For Citigroup, BlackBerry, RF Micro Devices, Amgen, and Microsoft Released By InvestorsObserver 9:31 a.m. July 15, 2014 - PR Newswire - PRF
Biotech Stocks Highlight -- Research on Celgene, Inovio Pharma, Amgen, and Array BioPharma 6:40 a.m. July 9, 2014 - PR Newswire - PRF
NDA Submission, Results Release Schedules, FDA Grants and Approvals, and Agreements - Analyst Notes on Gilead, Biogen Idec, Amgen, Illumina and MannKind 5:20 a.m. July 4, 2014 - PR Newswire - PRF
BIND Therapeutics Announces Completion of Collaboration Agreement with Amgen 4:01 p.m. July 2, 2014 - BusinessWire - BZX
Amgen Receives FDA Breakthrough Therapy Designation For Investigational BiTE® Antibody Blinatumomab In Acute Lymphoblastic Leukemia 8:09 a.m. July 1, 2014 - PR Newswire - PRF
Deciphera Pharmaceuticals Appoints Oliver Rosen M.D. as Chief Medical Officer 8:30 a.m. June 30, 2014 - BusinessWire - BZX
Leadership Appointments, Acquisitions, Orphan Drug Designations, Strategic Collaborations, and Technical Updates - Analyst Notes on Aerie, Medical Action, INSYS, Novadaq and Foundation Medicine 6:10 a.m. June 30, 2014 - PR Newswire - PRF
Collaborations, Clinical Study Results, and Laboratory Inspection Clearance - Analyst Notes on Amgen, Regeneron, Lexicon, WuXi PharmaTech and ImmunoGen 6:40 a.m. June 25, 2014 - PR Newswire - PRF
Critical Alerts For Walt Disney, Amgen, 3D Systems, Microsoft, and Lowe's Released By InvestorsObserver 9:31 a.m. June 23, 2014 - PR Newswire - PRF
Small health companies see large gains on a big earnings day 5:34 p.m. July 30, 2014 - Russ Britt
Twitter, U.S. Steel soar; Buffalo Wild Wings are burned 4:26 p.m. July 30, 2014 - Sue Chang
Edwards, Hospira rise as health-care companies see strong earnings 1:08 p.m. July 30, 2014 - Russ Britt
Amgen shares hit record on cost-cutting plans 10:50 a.m. July 30, 2014 - Russ Britt
Twitter shines; Fed statement and GDP due today 4:38 a.m. July 30, 2014 - MarketWatch
Amgen plans to cut up to 2,900 jobs 9:04 p.m. July 29, 2014 - MarketWatch.com
Twitter soars 33% in after hours as results surprise on upside 4:56 p.m. July 29, 2014 - Sue Chang
Amgen share climb 3.6% in after-hours trade after raised EPS outlook 4:38 p.m. July 29, 2014 - Tomi Kilgore
Amgen to cut up to 15% of workforce, ups EPS view 4:37 p.m. July 29, 2014 - MarketWatch.com
Amgen Q2 FactSet sales consensus $4.9 bln 4:31 p.m. July 29, 2014 - Jim Jelter
Amgen Q2 sales $5.18 bln vs $4.68 bln a year ago 4:31 p.m. July 29, 2014 - Jim Jelter
Amgen Q2 FactSet EPS consensus $2.07 4:30 p.m. July 29, 2014 - Jim Jelter
Amgen Q2 EPS $2.01 4:29 p.m. July 29, 2014 - Jim Jelter
The Fed meets; Twitter and Amex report results 4:32 a.m. July 29, 2014 - MarketWatch
The market in a minute: What will GDP mean for the market? 12:47 p.m. July 28, 2014 - The Trading Deck
PetSmart gains on Jana stake; Lorillard rallies 1:37 p.m. July 3, 2014 - Sue Chang
Synnex shares decline as outlook edges earnings 5:20 p.m. July 2, 2014 - Wallace Witkowski
Cytokinetics plunges 60% after Lou Gehrig's disease drug fails test 10:26 a.m. April 25, 2014 - Russ Britt
Apple, Facebook stuck in red ahead of earnings 3:03 p.m. April 23, 2014 - Sue Chang
Game day for Facebook and Apple, volume 'signalling the nasty' 6:50 a.m. April 23, 2014 - Barbara Kollmeyer
3 Stocks Reiterated As A Buy: VZ, QCOM, AMGN 12:44 p.m. Aug. 1, 2014 - TheStreet.com
Do Layoffs in Biotech Send the Right Message? 9:45 a.m. Aug. 1, 2014 - 247WallSt.com
Amgen Makes the Cut 12:25 p.m. July 31, 2014 - Barrons.com
Stock Market News for July 31, 2014 - Market News 10:10 a.m. July 31, 2014 - Zacks.com
Biotech Earnings Put These ETFs in Focus - ETF News And Commentary 10:01 a.m. July 31, 2014 - Zacks.com
Nasdaq Threatens to Break Double-Top 9:11 p.m. July 30, 2014 - InvestorPlace.com
Drug Firms Buy $67.5 Million Voucher to Speed FDA Review 7:21 p.m. July 30, 2014 - The Wall Street Journal Interactive Edition
Amgen - Continued Appeal With Shares Trading At Fresh All-Time Highs 5:25 p.m. July 30, 2014 - Seeking Alpha
U.S. Stocks End Mixed 4:31 p.m. July 30, 2014 - The Wall Street Journal Interactive Edition
Stock Market Today: Stocks Mixed as Fed Cuts Bond Buying to $25 Billion 4:31 p.m. July 30, 2014 - TheStreet.com
Stocks Mixed Despite Better-Than-Expected GDP 3:43 p.m. July 30, 2014 - benzinga.com
Stock Market Today: Stocks Slip Ahead of Fed Policy Announcement 1:50 p.m. July 30, 2014 - TheStreet.com
Amgen Price Target Raised by Various Analysts 12:42 p.m. July 30, 2014 - benzinga.com
Amgen Pleases the Street -- but Will Layoffs Keep Critics at Bay? 11:05 a.m. July 30, 2014 - TheStreet.com
Amgen Restructuring Plan, Q2 Earnings Send Stock Up 10:20 a.m. July 30, 2014 - Investors Business Daily
Stock Market News for July 30, 2014 - Market News 10:10 a.m. July 30, 2014 - Zacks.com
Trade-Ideas: Amgen (AMGN) Is Today's New Lifetime High Stock 9:45 a.m. July 30, 2014 - TheStreet.com
Amgen Beats on Q2 Earnings & Revs, Ups View & Plans Job Cuts - Analyst Blog 9:20 a.m. July 30, 2014 - Zacks.com
Will This Price Target Increase Help Amgen (AMGN) Stock Today? 9:02 a.m. July 30, 2014 - TheStreet.com
Amgen Reports Stellar Earnings, Raises Guidance 8:00 a.m. July 30, 2014 - benzinga.com
RBCC 3D Bioprinting Partner Awarded Prestigious Grant 6:54 a.m. July 31, 2014 - BusinessWire - BZX
Resilinc Named 2014 Great Supply Chain Partner by SupplyChainBrain 10:00 a.m. July 30, 2014 - Marketwire
Global Women%s Health Market 2014-2018 6:20 p.m. July 28, 2014 - PR Newswire - PRF
Amgen Announces 2014 Third Quarter Dividend 4:00 p.m. July 25, 2014 - PR Newswire - PRF
Bayer and Onyx Pharmaceuticals Report Phase 3 Trial Results of NEXAVAR® (sorafenib) in Patients with Advanced Breast Cancer 2:30 a.m. July 25, 2014 - PR Newswire - PRF
Amgen Announces Webcast of 2014 Second Quarter Financial Results 4:00 p.m. July 24, 2014 - PR Newswire - PRF
Surveyed U.S. and EU5 Dermatologists Indicate that Short-Term and Long-Term Effects on Psoriatic Plaque Clearance are Two Attributes that Most Strongly Influence Prescribing Decisions in Moderate to Severe Psoriasis 2:00 p.m. July 24, 2014 - PR Newswire - PRF
Amgen's Evolocumab is Set to Become the Clinical Gold-Standard Among Statin Add-On Therapies for Dyslipidemia 10:00 a.m. July 21, 2014 - PR Newswire - PRF
Colorado BioScience Association Recognizes Amgen Foundation’s $25,000 Investment in STEM Education in Colorado’s Classrooms 9:00 a.m. July 21, 2014 - BusinessWire - BZX
Amgen Announces Positive Phase 3 Results for AMG 416 for the Treatment of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease Receiving Hemodialysis 4:01 p.m. July 17, 2014 - PR Newswire - PRF
Global Pharmaceutical Survey 2013-2014 - Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry 4:27 p.m. July 15, 2014 - PR Newswire - PRF
Critical Alerts For Citigroup, BlackBerry, RF Micro Devices, Amgen, and Microsoft Released By InvestorsObserver 9:31 a.m. July 15, 2014 - PR Newswire - PRF
Biotech Stocks Highlight -- Research on Celgene, Inovio Pharma, Amgen, and Array BioPharma 6:40 a.m. July 9, 2014 - PR Newswire - PRF
NDA Submission, Results Release Schedules, FDA Grants and Approvals, and Agreements - Analyst Notes on Gilead, Biogen Idec, Amgen, Illumina and MannKind 5:20 a.m. July 4, 2014 - PR Newswire - PRF
BIND Therapeutics Announces Completion of Collaboration Agreement with Amgen 4:01 p.m. July 2, 2014 - BusinessWire - BZX
Amgen Receives FDA Breakthrough Therapy Designation For Investigational BiTE® Antibody Blinatumomab In Acute Lymphoblastic Leukemia 8:09 a.m. July 1, 2014 - PR Newswire - PRF
Deciphera Pharmaceuticals Appoints Oliver Rosen M.D. as Chief Medical Officer 8:30 a.m. June 30, 2014 - BusinessWire - BZX
Leadership Appointments, Acquisitions, Orphan Drug Designations, Strategic Collaborations, and Technical Updates - Analyst Notes on Aerie, Medical Action, INSYS, Novadaq and Foundation Medicine 6:10 a.m. June 30, 2014 - PR Newswire - PRF
Collaborations, Clinical Study Results, and Laboratory Inspection Clearance - Analyst Notes on Amgen, Regeneron, Lexicon, WuXi PharmaTech and ImmunoGen 6:40 a.m. June 25, 2014 - PR Newswire - PRF
Critical Alerts For Walt Disney, Amgen, 3D Systems, Microsoft, and Lowe's Released By InvestorsObserver 9:31 a.m. June 23, 2014 - PR Newswire - PRF
(0)
(0)
